New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers explore e-bikes for cancer recovery

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:
Hematology&Oncology December 20,2024
Researchers explore e-bikes for cancer recovery

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:
Hematology&Oncology December 20,2024
Prevention and screening outpace treatment advances for averting death from five cancer types, study reveals

Prevention and screening outpace treatment advances for averting death from five cancer types, study reveals

byNational Cancer InstituteCredit: Pixabay/CC0 Public DomainImprovements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than t
Hematology&Oncology December 20,2024
Prevention and screening outpace treatment advances for averting death from five cancer types, study reveals

Prevention and screening outpace treatment advances for averting death from five cancer types, study reveals

byNational Cancer InstituteCredit: Pixabay/CC0 Public DomainImprovements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than t
Hematology&Oncology December 20,2024
Urine test uses 'zombie' cell proteins for early detection of lung cancer

Urine test uses 'zombie' cell proteins for early detection of lung cancer

Credit: Pixabay/CC0 Public DomainScientists in the United Kingdom have created a world-first urine test that could indicate the first possible signs of lung cancer.Lung cancer is the third most common
Hematology&Oncology December 20,2024
Urine test uses 'zombie' cell proteins for early detection of lung cancer

Urine test uses 'zombie' cell proteins for early detection of lung cancer

Credit: Pixabay/CC0 Public DomainScientists in the United Kingdom have created a world-first urine test that could indicate the first possible signs of lung cancer.Lung cancer is the third most common
Hematology&Oncology December 20,2024
Fibroblastic reticula cells can organize T cells in the fight against lung cancer

Fibroblastic reticula cells can organize T cells in the fight against lung cancer

by Justin Jackson , Medical XpressGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.10.042Institute of Immunobiology-led research has made a significant breakthrough in under
Hematology&Oncology December 20,2024
Fibroblastic reticula cells can organize T cells in the fight against lung cancer

Fibroblastic reticula cells can organize T cells in the fight against lung cancer

by Justin Jackson , Medical XpressGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.10.042Institute of Immunobiology-led research has made a significant breakthrough in under
Hematology&Oncology December 20,2024
Researchers design novel immunotherapy for brain cancer

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm
Hematology&Oncology December 20,2024
Researchers design novel immunotherapy for brain cancer

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm
Hematology&Oncology December 20,2024
Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

by Julia Evangelou Strait,Washington University School of MedicineCredit: CC0 Public DomainAdding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening si
Hematology&Oncology December 20,2024
Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

by Julia Evangelou Strait,Washington University School of MedicineCredit: CC0 Public DomainAdding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening si
Hematology&Oncology December 20,2024
Recommendations to increase access to whole genome sequencing for children with cancer

Recommendations to increase access to whole genome sequencing for children with cancer

byWellcome Trust Sanger InstituteCredit:BMC Medical Education(2024). DOI: 10.1186/s12909-024-06219-yExperts have published a series of recommendations for improving equity of access
Hematology&Oncology December 20,2024
Recommendations to increase access to whole genome sequencing for children with cancer

Recommendations to increase access to whole genome sequencing for children with cancer

byWellcome Trust Sanger InstituteCredit:BMC Medical Education(2024). DOI: 10.1186/s12909-024-06219-yExperts have published a series of recommendations for improving equity of access
Hematology&Oncology December 20,2024
Possible colon cancer vaccine target uncovered in bacteria

Possible colon cancer vaccine target uncovered in bacteria

byWellcome Trust Sanger InstituteEscherichia coli. Credit: Rocky Mountain Laboratories, NIAID, NIHHigher rates of certain cancers in countries, such as the UK, may be linked to two particular st
Hematology&Oncology December 20,2024
Possible colon cancer vaccine target uncovered in bacteria

Possible colon cancer vaccine target uncovered in bacteria

byWellcome Trust Sanger InstituteEscherichia coli. Credit: Rocky Mountain Laboratories, NIAID, NIHHigher rates of certain cancers in countries, such as the UK, may be linked to two particular st
Hematology&Oncology December 20,2024
Menopausal status influences long-term benefit from anti-hormonal treatment, study shows

Menopausal status influences long-term benefit from anti-hormonal treatment, study shows

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainToday, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low
Hematology&Oncology December 20,2024
Menopausal status influences long-term benefit from anti-hormonal treatment, study shows

Menopausal status influences long-term benefit from anti-hormonal treatment, study shows

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainToday, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low
Hematology&Oncology December 20,2024
PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

by Elana GotkineAmong patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAAs), a serum protein induced by vitamin K absence
Hematology&Oncology December 20,2024
PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

by Elana GotkineAmong patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAAs), a serum protein induced by vitamin K absence
Hematology&Oncology December 20,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com